Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04517279 · ClinicalTrials.gov registry record · NA
Peer Approaches to Substances in Early Psychosis Programs: A Pilot Study of a Peer-Led Intervention
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
NCT04517279 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 113 participants.
The verdict
NCT04517279, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
Study Summary
The aim of the study is to pilot a peer-provided, manualized intervention to increase the proportion of young people with first episode psychosis who reduce or stop substance use and improve psychiatric and functional outcomes. Coordinated specialty care teams will be randomly assigned to implement the intervention, Peer Approaches to Substances in Early Psychosis Programs (PAS-EPP), or usual care. The pilot study aims to: (a) determine if peer providers can implement PAS-EPP with adequate fidelity; (b) determine if youth and young adults engage in the intervention with peer providers and find it acceptable; (c) estimate the rates of drop-out for each of the two study arms; (d) estimate both between-participant (within-provider team) and between-team variability on key outcome measures; and (e) identify any changes needed to the intervention approach, manual, or training materials. The pilot study will set the stage for a future comparative cluster randomized trial of the intervention;
Interventions
- BEHAVIORAL Peer Approach to Substances in Early Psychosis Programs
- BEHAVIORAL Usual Care Peer Services
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2023-08-22 |
| Est. Completion | 2025-07-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04517279
The ClinicalTrials.gov registry entry for NCT04517279 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peer Approach to Substances in Early Psychosis Programs is the first listed.
NCT04517279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04517279 about?
NCT04517279 is a clinical study titled "Peer Approaches to Substances in Early Psychosis Programs: A Pilot Study of a Peer-Led Intervention". The aim of the study is to pilot a peer-provided, manualized intervention to increase the proportion of young people with first episode psychosis who reduce or stop substance use and improve psychiatric and functional outcomes. Coordinated specialty care teams will be randomly assigned to implement ...
What is the current status of trial NCT04517279?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2023-08-22. Estimated completion is 2025-07-25.
What interventions are being tested in trial NCT04517279?
The interventions under investigation include: Peer Approach to Substances in Early Psychosis Programs (BEHAVIORAL), Usual Care Peer Services (BEHAVIORAL).
Who is sponsoring clinical trial NCT04517279?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.